E-LIB Suche - Ergebnisse für: Boerner, Scott A.

1

A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2..:

Maldonado, Edward ; Rathmell, W. Kimryn ; Shapiro, Geoffrey I....
Cancer Research Communications. , 2024

Link: https://doi.org/10.1158/..

2

NCI 7977: A Phase I Dose-Escalation Study of Intermittent O..:

Cecchini, Michael ; Walther, Zenta ; Wei, Wei...
Cancer Research Communications. 3 (2023) 6 - p. 1113-1117 , 2023

Link: https://doi.org/10.1158/..

3

Multicenter Phase II Trial of the PARP Inhibitor Olaparib i..:

Fanucci, Kristina ; Pilat, Mary Jo ; Shyr, Derek...
Cancer Research Communications. 3 (2023) 2 - p. 192-201 , 2023

Link: https://doi.org/10.1158/..

4

NCI10066: a Phase 1/2 study of olaparib in combination with..:

Cecchini, Michael ; Cleary, James M. ; Shyr, Yu...
British Journal of Cancer. 130 (2023) 3 - p. 476-482 , 2023

Link: https://doi.org/10.1038/..

5

Integrating comprehensive genomic sequencing of non-small c..:

Perdrizet, Kirstin ; Stockley, Tracy L. ; Law, Jennifer H....
Cancer Treatment and Research Communications. 31 (2022) - p. 100534 , 2022

Link: https://doi.org/10.1016/..

6

High Diagnostic Yield of Endoscopic Retrograde Cholangiopan..:

Nur, Abdulsemed M ; Salim, Misbah ; Boerner, Scott...
Journal of the Canadian Association of Gastroenterology. 5 (2022) 5 - p. 234-239 , 2022

Link: https://doi.org/10.1093/..

7

Molecular yield and cytomorphologic assessment of fine need..:

Ruff, Heather M. ; Lou, Si Kei ; Hahn, Elan...
Journal of the American Society of Cytopathology. 11 (2022) 3 - p. 142-153 , 2022

Link: https://doi.org/10.1016/..

8

Identifying treatment options for BRAFV600 wild-type metast..:

LoRusso, Patricia M. ; Sekulic, Aleksandar ; Sosman, Jeffrey A....
PLOS ONE. 16 (2021) 4 - p. e0248097 , 2021

Link: https://doi.org/10.1371/..

9

Validation of BRCA testing on cytologic samples of high‐gra..:

Lou, Si Kei ; Grenier, Sylvie ; Care, Melanie...
Cancer Cytopathology. 129 (2021) 11 - p. 907-913 , 2021

Link: https://doi.org/10.1002/..

10

Su1540 REVISITING THE DIAGNOSTIC YIELD OF ERCP BRUSH CYTOLO..:

Nur, Abdulsemed M. ; Boerner, Scott ; Edwards, Leanne..
Gastrointestinal Endoscopy. 91 (2020) 6 - p. AB371 , 2020

Link: https://doi.org/10.1016/..

11

Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Pr..:

Lou, Si Kei ; Ko, Hyang Mi ; Kinoshita, Tomonari...
Acta Cytologica. 64 (2020) 6 - p. 577-587 , 2020

Link: https://doi.org/10.1159/..

12

Anaplastic lymphoma kinase 5A4 immunohistochemistry as a di..:

Fiset, Pierre O. ; Labbé, Catherine ; Young, Kelvin...
Cancer. 125 (2019) 22 - p. 4043-4051 , 2019

Link: https://doi.org/10.1002/..

13

Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selecti..:

Cheung, Carol C. ; Barnes, Penny ; Bigras, Gilbert...
Applied Immunohistochemistry & Molecular Morphology. 27 (2019) 10 - p. 699-714 , 2019

Link: https://doi.org/10.1097/..

14

Benign Retinal Pigments Mimicking Pigment in Melanotic Mela..:

Wong, Willard ; Schwock, Joerg ; Boerner, Scott.
Journal of the American Society of Cytopathology. 7 (2018) 5 - p. S11 , 2018

Link: https://doi.org/10.1016/..

15

A phase 2 study of vorinostat in locally advanced, recurren..:

Goncalves, Priscila H. ; Heilbrun, Lance K. ; Barrett, Michael T....
Oncotarget. 8 (2017) 20 - p. 32918-32929 , 2017

Link: https://doi.org/10.18632..